Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

JCAHO (Joint Commission on Accreditation of Healthcare Organizations) vCJD (variant Creutzfeldt-Jakob disease) safety alert for surgeons:

This article was originally published in Clinica

Executive Summary

The Joint Commission on Accreditation of Healthcare Organizations has issued a safety alert to hospitals urging them to disinfect or dispose of instruments used in neurosurgery and when variant Creutzfeldt-Jakob Disease is suspected or confirmed. It also urged the hospitals to quarantine the instruments until an unclear diagnoses or biopsy has been clarified. Regular sterilisation techniques are not yet proven to be effective against the vCJD organism, which causes a degenerative and always fatal brain disorder. The hospital accreditation group issued the alert after hearing of two separate incidents at hospitals where as many as 14 patients may have been exposed to CJD. The patient operated on did not show symptoms of the disease prior to surgery.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072205

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel